Sugambhika Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.50 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
- Revenue Growth 19.70%
- Profit Growth 17.29%
- Ebitda 33.43%
- Net Worth 21.04%
- Total Assets 19.87%
About Sugambhika Pharmaceuticals
Sugambhika Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2018 (Six years and ten months 9 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.50 Cr.
Vadivelu Sakthivelan, Nathamoorthy Chitra, Narayanan Nathamoorthy, and Two other members serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304TN2018PTC121734
-
Company No.
121734
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Mar 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sugambhika Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vadivelu Sakthivelan
|
Director | 26-Mar-2018 | Current |
|
Nathamoorthy Chitra
|
Director | 26-Mar-2018 | Current |
|
Narayanan Nathamoorthy
|
Director | 28-Mar-2019 | Current |
|
Gayathri
|
Director | 28-Mar-2019 | Current |
|
Nathamoorthy Narayan
|
Director | 06-Sep-2023 | Current |
Financial Performance of Sugambhika Pharmaceuticals.
Sugambhika Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.7% increase. The company also saw a substantial improvement in profitability, with a 17.29% increase in profit. The company's net worth Soared by an impressive increase of 21.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sugambhika Pharmaceuticals?
In 2020, Sugambhika Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Pillbox Community Pharmacy Private LimitedNarayanan Nathamoorthy is a mutual person
Charges (Loans)
₹3.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2019 | Others | ₹3.50 Cr | Open |
How Many Employees Work at Sugambhika Pharmaceuticals?
Sugambhika Pharmaceuticals has a workforce of 28 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sugambhika Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sugambhika Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.